Status:
COMPLETED
Research for Predictive Biologic Parameters of Cutaneous Hypersensitivity After Brachytherapy in Breast Cancer
Lead Sponsor:
Centre Oscar Lambret
Conditions:
Breast Cancer
Eligibility:
FEMALE
60+ years
Phase:
NA
Brief Summary
25 patients, treated by brachytherapy in a phase II study "Mammosite" (from 2003 to 2005), will be asked to attend a clinical exam in order to evaluate the late cutaneous toxicity due to brachytherapy...
Detailed Description
This is an interventional study for the french law
Eligibility Criteria
Inclusion
- All patient treated by exclusive per-operative brachytherapy in the prior study Mammosite for breast cancer
- Patient with social security
Exclusion
- Not applicable
Key Trial Info
Start Date :
September 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2009
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT00922961
Start Date
September 1 2008
End Date
February 1 2009
Last Update
July 23 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Oscar Lambret
Lille, France, 59020